This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> CureVac (CVAC) upgraded to Buy from Neutral at UBS; tgt raised to $18
Downgrades:
> Cognizant Tech (CTSH) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $60
> DXC Technology (DXC) downgraded to Underperform from Market Perform at MoffettNathanson; tgt lowered to $28
Others:
> Alpine Immune Sciences (ALPN) initiated with an Overweight at Morgan Stanley; tgt $17
> CF Industries (CF) initiated with an Overweight at Wells Fargo; tgt $110
> Corteva (CTVA) initiated with an Overweight at Wells Fargo; tgt $78
> FMC Corp (FMC) assumed with an Overweight at Wells Fargo; tgt $148
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Source: Read Full Article
-
Treasuries See Further Upside On Continued Decline In GDP
-
Trump hit with gag order after lashing out at court clerk in NY fraud case
-
Top Analysts Pound the Table Now on 5 ‘Strong Buy’ Stocks Yielding 7% or More
-
5 Best and Worst Performing Mid-Cap Stocks in February 2023
-
Gunman in Paris kills three in attack on Kurdish centre, sparking protests

